Larvol Delta - A-Phase-2-Study-to-Evaluate-the-Pharmacodynamics-Safety-and-Tolerability-of-BGE102-in-Participants-With-Obesity-and-Cardiovascular-Risk-Factors

BGE-102 - BioAge Labs

http://clinicaltrials.gov/ct2/show/NCT07656727

Jun 19, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next